第17届EFMC关于小分子蛋白质降解剂的药用化学短期课程
Alessio Ciulli1, Suzanne O'Connor1, Chun-Wa Chung2
1Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee, DD1 5JJ Scotland, UK.
ChemMedChem
|October 11, 2023
概括
第17届EFMC短期课程专注于向蛋白质降解,这是药物设计的新前沿. 这次成功的活动汇集了专家,讨论了用于治疗开发的小分子蛋白质降解剂.
科学领域:
- 药用化学 医学化学
- 药物设计和开发 药物设计和开发
- 生物技术是生物技术.
背景情况:
- 第17届EFMC短期课程召开,以解决药物化学中的新兴趋势.
- 该课程特别侧重于针对性蛋白质降解这一新领域.
研究的目的:
- 报告第十七届EFMC医学化学短期课程.
- 总结关于小分子蛋白质降解剂的重要讲座和讨论.
- 突出针对性蛋白质降解在药物发现中的日益重要.
主要方法:
- 该活动包括由6名教师领导的讲座和讨论.
- 参加者包括来自欧洲,美国和南非的行业和学术界的35名参与者.
- 课程课程涵盖了小分子蛋白质降解剂的原理和应用.
主要成果:
- 该课程的订阅量过多,表明对向蛋白质降解有很大的兴趣.
- 关键话题包括小分子蛋白质降解剂的作用机制,设计策略和治疗潜力.
- 讨论强调了开发新型治疗方法的机遇和挑战.
结论:
- 第十七届EFMC短期课程成功提供了一个关于向蛋白质降解的知识交流平台.
- 小分子蛋白质降解剂代表了药物设计和开发的有希望的新途径.
- 该活动强调了该领域的跨学科性质和合作潜力.
相关概念视频
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


